Functional Fas expression in human thymic epithelial cells

Blood

Volumn 93, Issue 8, 1999, Pages 2660-2670

  Moulian, Nathalie ^a   Renvoizé, Claire ^b   Desodt, Colette ^b   Serraf, Alain ^b   Berrih Aknin, Sonia ^b  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; THYMUS;

EID: 0033560843     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.8.2660.408k09_2660_2670     Document Type: Article

References (55)

1. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
2. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima SI, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
3. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
4. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960, 1997
5. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373:438, 1995
6. Brunner T, Mogil RG, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Care CH, Green DR: Cell autonomous Fas (CD95)/Fas-ligand interaction mediate activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
7. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after activation. Nature 373:444, 1995
8. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Goldstein P: Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528, 1994
9. Yuan J: Transducing signals of life and death. Curr Opin Biol 9:247, 1997
10. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel, FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817, 1996
11. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85:803, 1996
12. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K, Sasada M: Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 187:587, 1998
13. Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411, 1995
14. Sprent J, Webb SR: Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol 7:196: 1995
15. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100, 1994
16. Anderson G, Moore NC, Owen JJT, Jenkinson EJ: Cellular interactions in thymocyte development. Annu Rev Immunol 14:73, 1996
17. Oosterwegel MA, Haks MC, Jeffry U, Murray R, Kruisbeek AM: Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class II-expressing thymic stromal cells. Immunity 6:351, 1997
18. Ogasawara J, Suda T, Nagata S: Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J Exp Med 181:485, 1995
19. Andjelic S, Drappa J, Lacy E, Elkon KB, Nikolic-Zugic J: The onset of Fas expression parallels the acquisition of CD8 and CD4 in fetal and adult αβ thymocytes. Int Immunol 6:73, 1994
20. Fisher GH, Lenardo MJ, Zuniga-Pflücker JC: Synergy between T cell receptor and Fas (CD95/APO-1) signaling in mouse thymocyte death. Cell Immunol 169:99, 1996
21. Zhou T, Fleck M, Müeller-Ladner U, Yang P, Wang Z, Gay S, Matsumoto S, Mountz JD: Kinetics of Fas-induced apoptosis in thymic organ culture. J Clin Immunol 17:74, 1997
22. Nishimura Y, Hirabayashi Y, Matsuzaki Y, Musette P, Ishii A, Nakauchi H, Inoue T, Yonehara S: In vivo analysis of Fas antigen-mediated apoptosis: Effects of agonistic anti-mouse Fas mAb on thymus, spleen and liver. Int Immunol 9:307, 1997
23. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365, 1994
24. Sytwu HK, Liblau R, McDevitt HO: The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17, 1996
25. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, Yoshida N, Nagata S: Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 93:2131, 1996
26. Castro JE, Listman JA, Jacobson BA, Wang Y, Lopez PA, Ju S, Finn PW, Perkins DL: Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5:617, 1996
27. Kishimoto H, Sprent J: Negative selection in the thymus includes semimature T cells. J Exp Med 185:263, 1997
28. Debatin KM, Süss D, Krammer PH: Differential expression of APO-1 on human thymocytes: Implications for negative selection? Eur J Immunol 24:753, 1994
29. Yonehara S, Nishimura Y, Kishil S, Yonehara M, Takazawa K, Tamatani T, Ishii A: Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int Immunol 6:1849, 1994
30. Moulian N, Bidault J, Truffault F, Yamamoto AM, Levasseur P, Berrih-Aknin S: Thymocyte Fas expression is dysregulated in Myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood 89:3287, 1997
31. Moulian N, Bidault J, Planche C, Berrih-Aknin S: Two signaling pathways can increase Fas expression in human thymocytes. Blood 92:1297, 1998
32. Leithauser F, Dhein J, Mechtershaimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Moller P: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415, 1995
33. Berrih S, Arenzana-Seisdedos F, Cohen S, Devos R, Charron D, Virelizier JL: Interferon-gamma modulates HLA class II antigen expression on cultured thymic epithelial cells. J Immunol 35:1165, 1985
34. Fadock VA, Voelker DR, Campell PA, Cohen JJ, Bratton DL, Henson PM: Exposition of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207, 1992
35. Vermes I, Haanen C, Steffens-Nakken H, Reutlingsperger C: A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Methods 184:39, 1995
36. Renvoizé C, Roger R, Moulian N, Bertoglio J, Bréard J: Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis. J Immunol 159:126, 1997
37. French LE, Wilson A, Hahne M, Viard I, Tschopp J, MacDonald HR: Fas ligand expression is restricted to nonlymphoid thymic components in situ. J Immunol 159:2196, 1997
38. high human thymocytes are activated and already functionally differentiated in helper and cytotoxic cells. J Immunol 152:1738, 1994
39. Shores EW, Van Ewijk W, Singer A: Maturation of medullary thymic epithelium requires thymocytes expressing fully assembled CD3-TCR complexes. Int Immunol 6:1393, 1994
40. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Müller C, Tschopp J: Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133:335, 1996
41. Xerri L, Devillard E, Hassoun J, Mawas C, Birg F: Fas ligand is not only expressed in immune privilege human organs but is also coexpressed with Fas in various epithelial tissues. J Clin Pathol 50:87, 1997
42. Suzuki A, Enari M, Eguchi Y, Matsuzawa A, Nagata S, Tsujimoto Y, Iguchi T: Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle. EMBO J 15:211, 1996
43. Quirk SM, Cowan RG, Huber SH: Fas antigen-mediated apoptosis of ovarian surface epithelial cells. Endocrinology 138:4558, 1997
44. Arscott PL, Knapp J, Rymaszewski M, Bartron JL, Bretz JD, Thompson NW, Baker JR Jr: Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor. Endocrinology 138:5019, 1997
45. Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer PH, Moller P: CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis. Gastroenterology 113:160, 1997
46. Suda T, Takahashi T, Goldstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
47. Suda T, Tanaka M, Miwa K, Nagata S: Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J Immunol 157:3918, 1996
48. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S: Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 186:2045, 1997
49. Mori S, Murakami-Mori K, Jewett A, Nakamura S, Bonavida B: Resistance of AIDS-associated Kaposiís sarcoma cells to Fas-mediated apoptosis. Cancer Res 56:1874, 1995
50. Chiba T, Takahashi S, Sato N, Ishii S, Kikuchi K: Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. Eur J Immunol 26:1164, 1996
51. Fournel S, Genestier L, Robinet E, Flacher M, Revillard JP: Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. J Immunol 157:4309, 1996
52. Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625, 1993
53. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT, Nicholson DW: CPP32/apopain is a key interleukin 1β involved in Fas-mediated apoptosis. J Biol Chem 271:1841, 1996
54. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, Flavell RA: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368, 1996
55. Kawahara A, Enari M, Talanian RV, Wong WW, Nagata S: Fas-induced DNA fragmentation and proteolysis of nuclear proteins. Genes Cells 3:297, 1998